Abstract

PreScription: New Drug Approvals 2022 and Compounding Opportunities

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2023 - Volume 27, Number 1

Page(s): 4

Download in electronic PDF format for $75
  • PreScription: New Drug Approvals 2022 and Compounding Opportunities Page 1

Abstract

Related Keywords

  • 2022 new United States drug approvals
  • compounding potential

Related Categories

  • BUSINESS
  • MARKETING

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2023
Pg. 4
PreScription: New Drug Approvals 2022 and Compounding Opportunities
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 444
PreScription: Compounded Drugs Often Become Manufactured Drugs
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 124-128
Inventory Information Approval System Certification and Flexible Spending Account Purchases: A New Year Brings Changes
Author(s): Shuey Brandon, Williams LaVonn A
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jul/Aug 2002
Pg. 271-273
Gaining Access to Investigational Drug for Treatment: An Investigational New Drug Application Primer
Author(s): Kramer Mark A, Grilley Bambi J
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
Mar/Apr 2015
Pg. 94-102
New England Compounding Center Indictment
Author(s): Cabaleiro Joe
Sep/Oct 2015
Pg. 377-380
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists
Author(s): Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
May/Jun 2006
Pg. 175-183
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States
Author(s): Stephenson Kenna, Jones William, Stephenson Douglas M M
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
Mar/Apr 2018
Pg. 108-121
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management
Author(s): Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun
Sep/Oct 2022
Pg. 358-362
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Author(s): Lopez C Vidal, Rios GL Quito
Jul/Aug 2010
Pg. 268
PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle
Author(s): Allen Loyd V Jr
Jan/Feb 2003
Pg. 21-23
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center
Author(s): Vail Jane
Mar/Apr 2021
Pg. 115-124
Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice
Author(s): Kelley Brian
Jul/Aug 2007
Pg. 350-351
PostScription: Thousands of Unapproved New Drugs are on the U.S. Market, Part 1
Author(s): Allen Loyd V Jr
Jan/Feb 2008
Pg. 38-47
View Sample
Disposing of Expired Drugs and Chemicals: New Options for Compounders
Author(s): Vail Jane